StockpollyBeta
Get App
Popularity #2,383
DRTS · NASDAQ · Biotechnology

Alpha Tau Medical (DRTS)

Develops Alpha DaRT, a localized alpha-radiation therapy for solid tumors.

$15.14
After hours−0.01 (−0.07%)
At close$15.15(−2.26%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Cost of revenue010000000000
Gross profit0−10000000000
998981091011131314
Research & development776768778101110
222223232324
Selling & marketing101111000000
General & administrative221222220324
Other expenses0−10000000000
Operating income−9−10−8−9−8−10−9−10−11−13−13−14
43021110−10−10−32
Interest income010211000000
Interest expense00000000001032
Other non-operating income00000−5000000
Income before tax−5−7−8−7−7−9−9−10−12−12−23−46
Income tax expense000000000000
Net income from continuing operations−5−7−8−7−7−9−9−10−12−12−23−46
Net income−5−7−8−7−7−9−9−10−12−12−23−46
EPS, basic−$0.07−$0.11−$0.11−$0.11−$0.10−$0.14−$0.12−$0.13−$0.14−$0.14−$0.26−$0.50
EPS, diluted−$0.07−$0.11−$0.11−$0.11−$0.10−$0.14−$0.12−$0.13−$0.14−$0.14−$0.26−$0.50
Weighted average shares, basic697070707070708085869091
Weighted average shares, diluted697070707070708085869091
EBITDA−9−9−8−9−8−5−9−9−11−11−13−14
Depreciation & amortization010000000100
EBIT−9−10−8−9−8−6−9−9−11−12−13−14